CSIMarket



Becton Dickinson And Company  (BDX)
Other Ticker:  
 
 

BDX's Operating Income Growth by Quarter and Year

Becton Dickinson And's Operating Income results by quarter and year




BDX Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter September - 496.00 255.00 110.00
III Quarter June - 628.00 358.00 626.00
II Quarter March 652.00 434.00 370.00 136.00
I Quarter December 815.00 1,241.00 501.00 888.00
FY   1,467.00 2,799.00 1,484.00 1,760.00



BDX Operating Income second quarter 2022 Y/Y Growth Comment
Becton Dickinson And Company achieved in the second quarter 2022, above Company average Operating Income rise of 50.23% year on year, to $ 652.00 millions.

Looking into second quarter 2022 results within Medical Equipment & Supplies industry 5 other companies have achieved higher Operating Income growth. While Becton Dickinson And Company' s Operating Income jump of 50.23% ranks overall at the positon no. 488 in the second quarter 2022.

Explain Operating Income growth


BDX Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter September - 94.51 % 131.82 % -80.74 %
III Quarter June - 75.42 % -42.81 % 22.03 %
II Quarter March 50.23 % 17.3 % 172.06 % -25.68 %
I Quarter December -34.33 % 147.7 % -43.58 % 286.09 %
FY   - 88.61 % -15.68 % 17.57 %

Financial Statements
Becton Dickinson And's second quarter 2022 Operating Income $ 652.00 millions BDX's Income Statement
Becton Dickinson And's second quarter 2021 Operating Income $ 434.00 millions Quarterly BDX's Income Statement
New: More BDX's historic Operating Income Growth >>


BDX Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter September - -21.02 % -28.77 % -82.43 %
III Quarter June - 44.7 % -3.24 % 360.29 %
II Quarter March -20 % -65.03 % -26.15 % -84.68 %
I Quarter December 64.31 % 386.67 % 355.45 % 55.52 %
FY (Year on Year)   - 88.61 % -15.68 % 17.57 %




Operating Income second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #6
Healthcare Sector #30
Overall #488

Operating Income Y/Y Growth Statistics
High Average Low
116.09 % 3.42 % -39.54 %
(Jun 30 2018)   (Jun 30 2017)
Operating Income second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #6
Healthcare Sector #30
Overall #488
Operating Income Y/Y Growth Statistics
High Average Low
116.09 % 3.42 % -39.54 %
(Jun 30 2018)   (Jun 30 2017)

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Becton Dickinson And's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
744.79 % 31.81 % -84.68 %
(Dec 31 2016)   (Mar 31 2019)


BDX's II. Quarter Q/Q Operating Income Comment
In the II. Quarter 2022 Becton Dickinson And Company reported fall in Operating Income sequentially by -20% to $ 652.00 millions, from $ 815.00 millions released in the previous quarter.

As we analyse recent slump in the quarter, we suppose to take into consideration, that commonly II. Quarter 2022 results emerge sluggish relative to the preciding period, Tuur Claes, Medical Equipment & Supplies industry researcher said.

Within Medical Equipment & Supplies industry 25 other companies have achieved higher Operating Income quarter on quarter growth. While Becton Dickinson And's Operating Income growth quarter on quarter, overall rank is 1339.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #26
Healthcare Sector #98
Overall #1339
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #26
Healthcare Sector #98
Overall #1339
Operating Income Q/Q Growth Statistics
High Average Low
744.79 % 31.81 % -84.68 %
(Dec 31 2016)   (Mar 31 2019)


BDX's II. Quarter Q/Q Operating Income Comment
In the II. Quarter 2022 Becton Dickinson And Company reported fall in Operating Income from the first quarter by -20% to $ 652.00 millions, from $ 815.00 millions released in the previous reporting period.

It's not important issue, as Operating Income generally gravitate to dip in the II. Quarter Tuur Claes, Medical Equipment & Supplies industry researcher wrote.

Within Medical Equipment & Supplies industry 25 other companies have achieved higher Operating Income quarter on quarter growth. While Becton Dickinson And's Operating Income growth quarter on quarter, overall rank is 1339.


Becton Dickinson And's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ 2,591.00 $ 2,373.00 $ 2,799.00 $ 2,558.00 $ 2,288.00
Y / Y Operating Income Growth (TTM) 13.24 % 6.7 % 88.61 % 91.04 % 42.38 %
Year on Year Operating Income Growth Overall Ranking # 934 # 181 # 517 # 318 # 631
Seqeuential Operating Income Change (TTM) 9.19 % -15.22 % 9.42 % 11.8 % 2.88 %
Seq. Operating Income Growth (TTM) Overall Ranking # 488 # 251 # 870 # 1059 # 1531




Cumulative Operating Income growth Comment
Although Becton Dickinson And's Annual Operating Income growth year on year were below company's average 14.49% , Operating Income announced in the Mar 31 2022 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 13.24% year on year, from 6.7% in Dec 31 2021.

In the Healthcare sector 59 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 181 to 934.

Operating Income TTM Q/Q Growth Statistics
High Average Low
116.09 %
3.42 %
-39.54 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 6
Healthcare Sector # 60
Overall # 934

Operating Income TTM Y/Y Growth Statistics
High Average Low
232.49 %
14.49 %
-66.08 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 30
S&P 500 # 488
Cumulative Operating Income growth Comment
Although Becton Dickinson And's Annual Operating Income growth year on year were below company's average 14.49% , Operating Income announced in the Mar 31 2022 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 13.24% year on year, from 6.7% in Dec 31 2021.

In the Healthcare sector 59 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 181 to 934.

Operating Income TTM Q/Q Growth Statistics
High Average Low
116.09 %
3.42 %
-39.54 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 6
Healthcare Sector # 60
Overall # 934

Operating Income TTM Y/Y Growth Statistics
High Average Low
232.49 %
14.49 %
-66.08 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 30
S&P 500 # 488




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
BDX's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for BDX's Competitors
Operating Income Growth for Becton Dickinson And's Suppliers
Operating Income Growth for BDX's Customers

You may also want to know
BDX's Annual Growth Rates BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio
BDX's Roa BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Comparisons



Companies with similar Operating Income fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2022
Merck and Co Inc 84.77%$ 84.771 millions
Maravai Lifesciences Holdings Inc 81.05%$ 81.050 millions
Option Care Health Inc 79.57%$ 79.573 millions
Catalyst Pharmaceuticals Inc 77.19%$ 77.186 millions
Iradimed Corp73.04%$ 73.040 millions
Viemed Healthcare Inc 68.77%$ 68.769 millions
Repligen Corp64.91%$ 64.912 millions
Surgery Partners Inc 56.14%$ 56.143 millions
Assertio Holdings inc 53.98%$ 53.976 millions
Integra Lifesciences Holdings Corp50.30%$ 50.303 millions
Becton Dickinson And Company50.23%$ 50.230 millions
Mednax Inc 49.82%$ 49.816 millions
Iqvia Holdings Inc 44.74%$ 44.737 millions
The Pennant Group Inc 44.20%$ 44.203 millions
Abcellera Biologics Inc 42.31%$ 42.307 millions
Bio rad Laboratories Inc 42.20%$ 42.197 millions
Abbott Laboratories38.07%$ 38.075 millions
Corcept Therapeutics Inc36.31%$ 36.312 millions
Medpace Holdings Inc 34.88%$ 34.883 millions
Bio techne Corp31.80%$ 31.797 millions
Bristol myers Squibb Company27.79%$ 27.790 millions
Ironwood Pharmaceuticals inc 27.42%$ 27.420 millions
Boston Scientific Corporation25.95%$ 25.946 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NBSE's Profile

Stock Price

NBSE's Financials

Business Description

Fundamentals

Charts & Quotes

NBSE's News

Suppliers

NBSE's Competitors

Customers & Markets

Economic Indicators

NBSE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071